Member Info for roger65

I have for the last four days. Always offered 4.16p. I see some people have bitten the bullet only to find themselves immediately down with the bid stuck at 3.6, over 10% down just for the privilege of owning some Prm shares. Hmmm let me think…

seems iniquitous to me that there is a test which is proven to prevent some babies from going deaf and will thus save the NHS far more money than the test would cost - not even thinking about the quality of life for that particular baby and their immediate families - but that the NICE panel deem it needs years more testing for observation and reporting before they will give it a thumbs up. Something rather skewed in that. There is no risk to the individuals so it's just a matter of money. I hope there is some organisation somewhere, a Trust or Foundation, that will gift the money to any NHS neonatal unit that chooses to use the test. I'd assumed if any NHS Trust chose to use it the NHS would fund it but that it wasn't mandatory for any trust to choose to adopt the test.

£130 per test? Hmmmm nah let's leave the kids alone and if they lose their hearing that's just too bad. I wonder what a news channel would make of this...?

No. Sold out at 12.5p on the way down just after war started in Ukraine. Didn't see any hope there at all until the war was over. Was becoming more and more disillusioned anyway with the length of time everything was taking and never having clear comms from the BODs.

Sorry folks. Since I jumped in it's struggling. i have that effect on most shares I buy into sadly.

Anyone know of any other partners focused on Genomics that Manchester University are working with other than GDR?

This funding pot from the Govt is £100m and spread over two years and three centres, Greater Manchester being one of them. Approximately £16.5m for each centre per year. I can't find anything on any other company working in this field and already established alongside MU so think it just has to be GDR. they won't get all of that money of course but I do think a decent chunk might well end up in their laps. Just have to hope David Budd won't try and snaffle it all up on a salary increase with bonuses for himself :)

I obvs don't know for sure but i really do think some of this is coming GDR's way.

Published 20th March 2023. Part of a longer article announcing GMU secures funding support...
'a programme to develop a pipeline of new genomic technologies will be established, in collaboration with the University of Manchester. The Development and Validation of Technology for Time Critical Genomic Testing (DEVOTE) Programme will bring together academic, industry and clinical partners from across the region to deliver enhanced genomic diagnostics to prevent stroke; rapid genetic point of care devices to detect genetic changes; and the development of ‘pharmacogenetic passport’ to optimise precision medicines for patients.'

No idea what's caused the recent rise but I'm not complaining.

Took a look at the VDTK website and Bradclad are STILL there with their Logo. I thought they had reneged on an agreement and caused one of the recent huge slumps to the sp? Makes me wonder if VDTK have anyone working at all for them these days as the only changes to the website for as long as i can remember seem to be the additions on the Regulatory News updates.

Helloooo! Is there anyone there? I'm hoping for another announcement of some more orders like the recent one in Belgium. A few more of those and things will start to change here for the better.

Ah lohmaikai, such an edifying addition to the bb. Think with just a handful of posts you've beaten the all time record for me to bin someone. What utter carp you write (or try to) and with some real bitterness too.

I really hope so Bladderman. I could do with a quick win for a change rather than yet another stock I buy into which slumps and then I end up having to just wait for sometimes years just to get my money back. I've had a few 'winners' but know it's all a bit of a casino - even if GST isn't on AIM! Wish I'd held on here with my original £7k at 0.4. I did clear some profit from trading for a couple of months but nothing like as much as if I'd just held. 2p will do me and I'll be on my way.

Loads and loads of my green boxes have disappeared so perhaps LSE have finally done something about the disruption being caused by certain posters eg MassiveRay, Truant, Bruno10 and Bankrupt with their relentless drivel. Hope so.

This is the paragraph from the RNS

'The Directors have assessed a number of financing options for the Company including an equity raise but believe that the Facility is the best option available to the Company at the present time in order to further fund the Company's progress while also taking consideration of the investor shareholder base. Further, the Directors believe that a combination of the possibility of positive future news flow around the Company's two main assays as well as the potential for reasonable levels of liquidity in the Company's ordinary shares make the Facility the most attractive form of financing for the Company at the current time. '

is that the two issues upon which the BOD considered the RF funding package the best deal available are both very much in deficit at the moment. No positive news and liquidity has almost dried up. That means RF go into 'attack' mode and short the stock - and I'm sorry but investors find ways of not declaring being short on stocks all the time so you can't rust what it states on this LSE website - and go all out to get as many shares as possible and apply more pressure to have the 2nd tranche of money taken on. Essentially if things went well then the RF deal would be ok and manageable and even possibly GDR might have avoided the next draw down. If things don't go well, and we're now in another of Budd's long silent periods of no news at all AND no decent liquidity, then the RF deal does indeed start to look more and more like a DSF deal which will ultimately cost share holders dear.

For me if we can stay above support of 21p we stand a decent chance of making good gains once more but if it drops below that then it's time to run for the hills.

Budd needs to find a way of drastically reducing the monthly spend as no company can sustain monthly costs of £350 - 3450 per month whilst earning only £50k every six months. Certainly not for another 4 yrs until there will be meaningful sales - if you believe what Starres is telling us now. Imho if there aren't good sales by the end of this year then GDR will either go bust or be taken for peanuts by someone.

* good* news...

I've jumped in. Glad I waited a little but managed this week to get £25k at an average of 1.42p. Late to the party but...gotta be in it to win it.

OK now let's see if this really does make it's way to 2p. Hopefully it doesn't retrace any further as news gets closer. If it IS god news then 2p should be easily doable.

Starres - you’ve changed your tune!

‘I would say significant sales from NHS for either products are about 4 years away from starting (my optimistic scenario)’

And what if the strike marker test gets Best Practise’ approval from NICE in August?

Overly pessimistic now so can’t agree. I’m not confident in abuse delivering good news but 4years to get to significant sales and revenue? Think the company is more likely to either go bust in that time or be taken over for peanuts. Don’t see either of those scenarios as very likely at all.

By end of this year - as long as RF funding can be held in check - GDR will imv be doing well again.

The two things that could rescue our current plight are a) news of some funding from DEVOTE or b) being approved for one of the faster and cheaper routes in FDA application.

Either would see sentiment quickly return here.

There will be other assays that GDR are be working on that cd we’ll qualify for funding. We just might not know about them yet…

Erm it appears the sp is still not above 2p. In fact I’d a long way off. I thought several people posted here a couple of weeks ago saying it wd definitely be going over 2p. What’s happened?

Let’s hope we don’t have another 6 weeks of silence from Budd followed by news of the first draw down of £300k.

No one’s gonna buy whilst this stupid spread is in place.

?? You must be joking!

Gotta link pls Starres? Tks

Starres - no financial mandate for AIHL in the NHS. You said there is no money for it but I think you may be wrong. As I’ve read this it means if NHS Trusts or hospitals want to adopt the kit then funds WILL need forthcoming but no one HAS to adopt the AIHL tests ie not mandatory. What you state implies the 7 or 8 hospitals already lined up to start using AHIL tests in the next couple of months are just going to find the money for it themselves. I’d be amazed if that’s the case so I think this issue is with everyone here looking into just so it can be clarified.

Starres - you think GDR will now struggle right up to the end of the year and not generate sales until 2024 at the earliest?

we were told bu Budd that the financial deal with RF was put together after the NICE news was announced. Seeing as the news wasn't quite as earth shatteringly positive as we'd hoped ie 'Best practise' Budd will have known well before hand things stand sales wise in the UK (within the NHS) and also the numerous distributors abroad. Therefore I think it odd he wouldn't have gone all out for more money from RF. Why in two tranches too? My feeling, and that's all it is, is that there is a chance of getting good news from somewhere sooner than 2024 and with it a chance to opt out of the 2nd tranche of RF funding. Even managing to announce that wasn't going to be required would send good vibes to the market.

Budd will have known about the delays in having the stroke marker test reviewed by NICE and that a result of any kind is now not due until August. If he needs more money to get AIHL out there, and he clearly does, then why not just announce £5m in one go and try for better terms? I'm not upbeat about GDR just at the moment but I think you might be painting a blacker picture of how far off news might be. I think six months from March so by Aug or Sept at the latest. The sp can turn quickly on news or even just expectation so I don't think we're going to have to wait until 2024 myself.

Whether or not Budd will play ball and deliver something positive soon is anyone's guess though.